Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-09-30, Stock:JNJ, The news for the past five days is as follows:
2021-09-23: NEWS1: Pfizer Nabs Booster OK In U.S. — But How Long Will It Hold The Covid Lead?.NEWS2: Pfizer (PFE) Booster Dose Gets FDA Nod for High-Risk People.NEWS3: FDA Authorizes Pfizer Booster for Some Americans. The CDC’s Call on the Rollout Could Come Today..NEWS4: Markets Defy Fed’s Hawkish Shift. Here’s Why..NEWS5: 3 Relatively Safe Pharma Stocks You Can Buy Right Now.NEWS6: Anne Wojcicki on comparison to Elizabeth Holmes: ‘Theranos was never transparent’.NEWS7: Influencers with Andy Serwer: Anne Wojcicki.NEWS8: Pfizer Covid-19 Booster Shouldn’t Be for Moderna, J&J Vaccine Recipients, Health Official Says.
2021-09-24: NEWS1: COVID SCIENCE-Vaccinated pregnant women pass protective antibodies to babies.NEWS2: Wolfgang Puck on restaurant industry staffing hurdle: ‘Wages are not the issue’.NEWS3: ‘I don’t think we’ve done enough to get vaccines overseas’: Doctor.NEWS4: EXPLAINER-Who can get a COVID-19 vaccine booster in the United States?.NEWS5: CDC guidance exacerbates confusion over COVID-19 boosters.NEWS6: Pfizer (PFE) Booster Dose Gets CDC Backing for Older Adults Only.NEWS7: CDC approves Covid booster shots for those over 65.NEWS8: ‘Wildly political’ environment around vaccines creates room for ‘new leadership’: 23andMe CEO.NEWS9: If You Like Dividends, You Should Love These 3 Stocks.NEWS10: Pharma Stock Roundup: PFE Booster Jab Gets FDA Nod, JNJ's New Data on COVID-19 Shot.NEWS11: AstraZeneca - Merck's Lynparza Delays Disease Progression In Prostate Cancer Patients.NEWS12: Healthcare is still ‘stuck in a world of white coats’: 23andMe CEO.NEWS13: 'A lot of the [COVID-19] morbidity' is from unvaccinated individuals: Doctor.NEWS14: J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data.
2021-09-27: NEWS1: List of eligible booster candidates will grow: Osmosis Chief Medical Officer.NEWS2: J&J's Xarelto Tops Aspirin With Fewer Blood Clots In Pediatric Patients.NEWS3: Doctor on Covid: Another variant of concern is anticipated to come in the future.NEWS4: 10 Cheap Pharmaceutical Stocks to Watch.NEWS5: Harvard MBA courses move online amid COVID spikes.NEWS6: Billionaire Ray Dalio is Buying These 10 Stocks.NEWS7: CDC Director warns about Delta-hit areas of U.S; Pfizer CEO predicts ‘normal life’ within a year.NEWS8: 10 Best German Stocks to Buy Now.
2021-09-28: NEWS1: Johnson & Johnson (JNJ) Stock Moves -0.22%: What You Should Know.NEWS2: Barring new variant 'we're close' to return to normal: Doctor.NEWS3: Acceleron (XLRN) Stock Up on Takeover Rumors for $11 Billion.NEWS4: CDC 'starting to see mix-and-match data' for COVID-19 vaccines: Director.NEWS5: Yahoo Finance Presents: CDC Director Dr. Rochelle Walensky.NEWS6: Johnson & Johnson Celebrates COVID-19 Vaccine Science Superheroes.
2021-09-29: NEWS1: Here's Why Right Now Is a Great Time to Invest in the Stock Market.NEWS2: Here's How a New Investor Started Her Portfolio With Just 10 Top Stocks.NEWS3: Here's Why Investors Shouldn't Count Out Johnson & Johnson as a Coronavirus Vaccine Stock.NEWS4: Here's Why Johnson & Johnson Is a Stock You Can Buy and Hold Forever.NEWS5: UPDATE 1-Slovenia temporarily suspends J&J's Janssen COVID-19 vaccine.NEWS6: UPDATE 1-Swiss buy 150,000 doses of J&J COVID-19 vaccine.NEWS7: Swiss buy 150,000 doses of J&J COVID-19 vaccine.

Answer: Decrease